Mānuka Honey and IBS / IBD: What Research Has and Has Not Shown

Headlines linking Mānuka honey to relief from irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) have outrun the actual published evidence. This is the kind of post the previous version of this site got wrong; this rewrite addresses what is actually known.

What is actually published

Most of the published research linking honey or methylglyoxal to gastrointestinal effects is preclinical, meaning in cell cultures or animal models, not in humans. Honey's broad antibacterial and modulatory effects on gut bacteria have been demonstrated in vitro (Carter et al., 2016, Frontiers in Microbiology), but translating these to clinical IBS or IBD outcomes is a different matter.

Bilgehan et al. and others have explored honey's effect on gut inflammation in rat models, with some studies reporting reduced inflammatory markers. These are mechanistic findings, not treatment endorsements.

For IBD specifically (Crohn's disease, ulcerative colitis), no large-scale human randomized trial has tested Mānuka honey as a treatment. For IBS, the same is true.

Why honey may actually worsen GI symptoms

Honey is high in fructose and contains fructans, both of which are FODMAPs. People with IBS or fructose malabsorption frequently experience worsened bloating, gas, and abdominal pain after consuming high-FODMAP foods, including honey. Standard IBS dietary guidance from gastroenterology associations typically lists honey as a high-FODMAP food to limit during symptom flares.

The honest answer

The evidence does not currently support recommending Mānuka honey for IBS or IBD. The claim that it "reduces IBS / IBD symptoms" is not consistent with what has been published. People managing these conditions should work with their gastroenterologist or dietitian and follow established dietary protocols.

What this means for buyers

If you are interested in Mānuka honey for general use and you have IBS or IBD, talk to your clinician before incorporating it. The evidence base for Mānuka in this clinical area is preliminary and the FODMAP load may worsen symptoms.

If you do not have a GI condition, Mānuka can be enjoyed as a sweetener or culinary ingredient. See our roundup for current options.

Sources

• Carter DA, Blair SE, Cokcetin NN, et al. Therapeutic Mānuka Honey: No Longer So Alternative. Frontiers in Microbiology. 2016;7:569.
• Bose K, Naidu V. Effects of honey on inflammatory markers: a review of preclinical evidence. Journal of Inflammation Research. (Multiple preclinical studies; readers should consult current systematic reviews for an updated picture.)
• Monash University FODMAP Diet App documentation. Honey is classified as high-FODMAP at typical serving sizes.